Showing results (151-160 of 171) with videos related to
Sort By:
Pageof 18
British Journal of Cancer|November 27, 1999
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasisJ W Clark, L Snell, R P Shiu, et al.The Annals of Thoracic Surgery|November 1, 1995
Comparing two strategies of cardiopulmonary bypass cooling on jugular venous oxygen saturation in neonates and infantsF H Kern, R M Ungerleider, S R Schulman, et al.British Journal of Cancer|July 7, 2000
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanomaE F McClay, M E McClay, L Monroe, et al.Journal of the American College of Surgeons|July 11, 1998
Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panelM A Lockett, P L Baron, P H O'Brien, et al.Surgery|August 3, 2000
The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancerJ R Kelley, J M Brown, M M Frasier, et al.American Journal of Surgery|March 15, 2001
Melanoma thickness and histology predict sentinel lymph node statusC L Nguyen, E F McClay, D J Cole, et al.Cancer Research|October 15, 1994
Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitopeD J Cole, D P Weil, P Shamamian, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Identification of a T-cell receptor from a therapeutic murine T-cell cloneJ Shilyansky, J C Yang, M C Custer, et al.Surgery|July 1, 1994
Postoperative complications in patients receiving suramin therapyD J Cole, S E Ettinghausen, H I Pass, et al.Cancer Gene Therapy|March 9, 2013
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapyE R Camp, C Wang, E C Little, et al.Pageof 18